-
Mending the fabric of your genes
6 min read
Latest News
-
Huntington's Disease Therapeutics Conference 2016 – day 1
12 min read
Proteins and DNA – Jeff and Ed report from day 1 of the 2016 #huntingtonsdisease therapeutics conference
-
Harnessing the power of viruses to treat Huntington's disease
7 min read
Researchers design a virus to more effectively deliver gene-silencing drugs throughout the brain.
-
Through a Broader Lens: Looking at Non-Motor Symptoms in HD
8 min read
Sleep deficits precede motor problems in HD
-
Looking Past the Spin: Results from a Clinical Trial of Cysteamine
6 min read
Phase 2/3 clinical trial results prove inconclusive for Huntington's drug cysteamine.
-
A recycled drug gives us new insight in to HD
7 min read
An existing drug could give a boost to HD brain cells – but it may need more testing before it’s back in the clinic
-
Through the eyes of a friend: changes in mood and behavior in early HD
8 min read
Companions of HD gene carriers are more likely to notice psychological changes in presymptomatic HD.
-
A multiple sclerosis drug that works for Huntington's disease: the real deal or too good to be true?
8 min read
Fingolimod, a drug used in multiple sclerosis, prevents memory problems in HD mice. Would it work in patients?
-
Mapping the anatomy of HD: a whole-brain history
10 min read
A new book for researchers describes a century of HD anatomy and presents evidence that HD affects the whole brain.
-
Liftoff: First humans treated with gene silencing drugs for HD!
8 min read
Major Announcement: First HD patients treated with gene silencing drugs
-
HDBuzz primer: Clinical trial designs and phases
17 min read
HDBuzz untangles hope from hype in clinical trial announcements
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
